ABOUT US

Discovery:
-MDI discovers, patents, and evaluates new drug candidates.
-MDI out licenses its proprietary drugs to pharmaceutical companies having the resources to develop them through the regulatory process and to market them aggressively.

Contract Research and Development:
- Drug Discovery
-Custom Synthesis
-Preclinical Studies
-Clinical Studies
-MDI has conducted contract Research and Development in the private sector and under contract with the United States Government.

Background:
-MDI was founded in 1975. 
-MDI is involved in discovery and out-licensing of innovative pharmaceutical compounds.
-MDI has successful licensing arrangements with various pharmaceutical development companies.
-MDI has a full pipeline of promising compounds in various stages of discovery.
-MDI focuses in the fields of oncology, dermatology, diabetes, and obesity.

Key Features:
-MDI has only two full-time employees.
-Research is conducted on a contract basis by selecting the world’s leading experts.
-This flexibility allows us to use the best resources in the world.
-Research are at a premium but are cost-effective in the long run

  
Available for Licensing:

Obesity- Preclinical stage of development. Four US Patents issued.  Foreign patents pending. 

Diabetes- Preclinical stage of development. Four US Patents issued. Foreign patent pending.

Oncology-  Preclinical testing ongoing.  Further funding needed for animal studies and toxicology to file an IND.

Dermatology- Preclinical testing is ongoing for Wound Healing.  Two compounds have been sold to the Cosmetics Industry and one is currently on the market.  

Partners and Collaborators    
-MDI partners with large pharmaceutical companies to help develop drugs and bring them to market.
-MDI partners with individuals and companies to help fund research.
-MDI partners with scientists to develop their discoveries through patenting, research, grants, funding and marketing.
-MDI has a selected network of outstanding professional collaborators:

β3 Expert-  Jonathan Arch

Oncology-  Jacqueline M. Bentel, Ph.D., Royal Perth Hospital

Pharmacology-  Dennis Feller, Ph.D., University of Mississippi

Dermatology-  Howard Maibach, M.D., University of California SF

Medicinal Chemistry-  Duane Miller, Ph.D., University of Tennessee

Pharmacology-  James Varani, Ph.D., University of Michigan